Comparison of the effectiveness of treatment of iron deficiency anemia with daily vs. every other day oral iron supplementation

Arak University of Medical Sciences0 个研究点目标入组 376 人开始时间: 待定最近更新: 2021年11月1日

适应症

试验速览

暂无简介。

•Age = 15 years and less than 50 years
•outpatients Women with iron deficiency with ferritin less than 30 micrograms per liter
•No pregnancy
•No breastfeeding right now
•Absence of comorbidities (ckd, DM, IHD, etc.)
•Lack of known history of inflammatory bowel disease
•Lack of known history of celiac disease
•No known history or thalassemia
•No known hereditary bleeding disorder
•Do not take multivitamin and mineral supplements (35 mg or more of essential iron per day) in the 2 weeks prior to randomization.
•No allergy to oral iron
•Lack of intravenous iron therapy in the last 12 weeks
•Do not receive anticoagulants (eg warfarin, apixaban, debigatran, adoxaban, Riveroxban)
•Lack of creatinine clearance less than 30 ml per minute
•Lack of hemoglobin less than 80 g / l with active bleeding
•No chemotherapy planned for the next 12 weeks.
•No surgery is scheduled for the next 12 weeks.

•Intolerance or non-response to oral iron gluconate, sulfate or fumarate in the last 12 weeks
•Received frequent anemia treatments and are resistant to anemia treatment.
•Dissatisfaction to participate in the study or lack of cooperation and consent to continue treatment

发起方